Karen Licitra - Novadaq Technologies Director

NVDQ Etf   5.21  0.43  7.62%   
Karen Licitra is Portfolio Manager at Novadaq Technologies
Ms. Karen A. Licitra was appointed as Director of the Company. Ms. Licitra has a track record of accomplishments in sales, marketing, commercial and general management in the global healthcare industry. In her career with Johnson Johnson that spanned over 30 years, she most recently served as Corporationrationrate Vice President Worldwide Government Affairs Policy before retiring in August 2015. Prior to her role in governmental affairs, Ms. Licitra was Worldwide Chairman, Global Medical Solutions Group within Johnson Johnson Medical Device and Diagnostics segment. In that role, she was responsible for setting the strategy and vision for an 8.6 billion global portfolio of healthcare companies including VisionCare, Diabetes Care, Ortho Clinical Diagnostics, and Advanced Sterilization Products, as well as the Sedation business unit. She also led the Medical Device Diagnostics center of excellence for regulatory affairs. Before her rise to Worldwide Chairman, Ms. Licitra was Company Group Chairman for Johnson Johnson and Worldwide Franchise Chairman for Ethicon EndoSurgery, Inc. and Johnson Johnson Medical, Canada. She is a member of the board of directors of SIBone, Inc. and was a member of the Board of Trustees for the Saint Peter Healthcare System
Tenure 8 years
Professional MarksMBA
Phone905-629-3822
Webwww.novadaq.com
Licitra also served as Chair Emeritus for the Campaign to End Obesity, which advances U.S. national policy and platforms to combat obesity, as well as Chair of the Campaign Advisory Council. She was named to Fortune 50 Most Powerful Women in Business list in 2012.

Similar Fund Executives

Found 7 records

One Year Return

Peter FlintZillow Group Class
40
April UnderwoodZillow Group Class
35
Gregory WaldorfZillow Group Class
46
Gordon StephensonZillow Group Class
50
Gregory MaffeiZillow Group Class
55
Erik BlachfordZillow Group Class
49
Jay HoagZillow Group Class
58
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging solutions for use by surgeons in the operating room and other clinical settings in the United States and internationally. Novadaq Technologies [NVDQ] is traded in USA and was established null.

Novadaq Technologies Money Managers

Anthony Griffiths, Independent Non-Executive Chairman of the Board
Patrice Merrin, Director
Lori Swalm, VP of Marketing
Thomas Wellner, Independent Director
Lisa Colleran, Director
Arun Menawat, President CEO, Director
Rick Mangat, Co-Founder, Sr. VP and General Manager
Harold Koch, Independent Director
David Martin, IR Contact Officer
Robert White, Director
Karen Licitra, Director
Aaron Davidson, Independent Director
Derrick Guo, General Counsel
William MacKinnon, Independent Director
Roger Deck, Vice President - Operations

Novadaq Etf Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Novadaq Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novadaq Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novadaq Technologies' short interest history, or implied volatility extrapolated from Novadaq Technologies options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novadaq Technologies. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Novadaq Etf, please use our How to Invest in Novadaq Technologies guide.
Note that the Novadaq Technologies information on this page should be used as a complementary analysis to other Novadaq Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
The market value of Novadaq Technologies is measured differently than its book value, which is the value of Novadaq that is recorded on the company's balance sheet. Investors also form their own opinion of Novadaq Technologies' value that differs from its market value or its book value, called intrinsic value, which is Novadaq Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novadaq Technologies' market value can be influenced by many factors that don't directly affect Novadaq Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novadaq Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novadaq Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novadaq Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.